Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Current Treatment Options in Oncology
Gabriela Motyckova, Richard M Stone
Annals of Hematology
Marysia HengeveldTheo de Witte
The New England Journal of Medicine
Hugo F FernandezMartin S Tallman
Haematology and Blood Transfusion
P A CassilethM J O'Connell
The Hematology Journal : the Official Journal of the European Haematology Association
Massimo OffidaniPietro Leoni